The 3 analysts offering 12-month price forecasts for Aslan Pharmaceuticals Ltd have a median target of 8.00, with a high estimate of 8.00 and a low estimate of 8.00. The median estimate represents a +409.55% increase from the last price of 1.57.
The current consensus among 4 polled investment analysts is to Buy stock in Aslan Pharmaceuticals Ltd. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.12
Reporting Date Nov 04
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.